Form D · Other

Viamet Pharmaceuticals Holdings LLC

Durham, NC · CIK 0001538928

Offering snapshot reported Sep 28, 2016 · SEC filing

Reported sold
$12M
Offering amount: $48M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 21, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 28, 2016Initial$12,000,014No comparison12SEC filing
Mar 12, 2014Initial$10,000,000No comparison7SEC filing
Jun 17, 2013Amendment$10,000,000$7,000,000vs Oct 16, 20127SEC filing
Oct 16, 2012Initial$3,000,000No comparison6SEC filing
Jan 17, 2012Initial$39,600,000No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-271439

Source: Form D, filed Sep 28, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth Bahk Director
Jeffrey Edwards Director
Adrian Howd Director
Robert Ingram Director
Richard Katz Executive
G. Kelly Martin Director
Neil Moore Executive
Douglas Reed Director
James Rosen Director
Robert J. Schotzinger, M.D., Ph.D. Director, Executive
Lauren Silverman Director
S. Edward Torres Director
Philip R. Tracy Director
Andrew Von Eschenbach Director
Steven D. Weinstein Director
William T. White Iii Director
Kristopher A. Wood Director

Issuer details

Industry: Other (See others in industry)

Address:
4505 Emperor Blvd Suite 300
Durham, NC, 27703